Vistra Q2 Call Keeps 2026 Guidance, ERCOT Softness Clouds 2027

What happened

Vistra’s Q2 earnings call reaffirmed its full-year 2026 guidance for Ongoing Operations Adjusted EBITDA of $6.8–$7.6 billion and Adjusted FCFbG of $3.9–$4.7 billion, supported by near-complete hedging of expected generation volumes. Management highlighted robust data center demand and long-term hyperscaler PPAs as structural growth drivers, but acknowledged that softer ERCOT pricing is clouding the outlook for 2027 open positions. The call provided no incremental updates on the two critical near-term catalysts—the expected 2H26 close of the Cogentrix acquisition and the commencement of Meta PPA operating deliveries—leaving their timing subject to regulatory and execution risks. While the reaffirmed guidance offers short-term visibility, the market’s focus remains on 2027+ repricing potential as hedges roll off, with PJM/FERC rule reforms adding policy uncertainty to the merchant narrative. The update reinforces a cautious view that Vistra’s AI-power thesis remains back-end loaded and dependent on milestones that have yet to be achieved, warranting a wait-and-see approach.

Implication

The maintenance of 2026 guidance supports the base-case EBITDA and FCF, but the stock’s ~14x EV/EBITDA multiple already prices in a durable earnings stream. Softer ERCOT pricing signals that the 2027 repricing catalyst—central to the bull case—faces growing headwinds, potentially delaying the earnings uplift from AI-driven demand. The absence of progress on the Cogentrix deal or Meta delivery milestones means the thesis remains reliant on 2H26 events that have not yet materialized. With heavy hedging muting near-term upside, the equity is more exposed to policy and execution risks than to AI-demand optionality in the short run. Investors should therefore maintain a wait-and-see posture, only adding exposure on further signs of on-schedule execution or a pullback toward the $140 attractive entry level.

Thesis delta

The investment thesis remains a WAIT, but the Q2 call introduces explicit caution on ERCOT as a 2027 headwind, marginally weakening the already-tempered bull case. While 2026 guidance is secure, the back-end loaded nature of AI-related earnings means the stock’s risk/reward continues to skew unfavorable until key milestones are confirmed.